{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-002847","form_type":"8-K","ticker":"ICU","cik":"0001831868","company_name":"SeaStar Medical Holding Corp","filed_at":"2025-01-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.149959+00:00","generated_at":"2026-05-28T03:46:30.362323+00:00","sec_items":["7.01","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"SeaStar Medical reports 5,997,246 shares outstanding; updates on clinical and commercial progress","bullets":["As of Dec 31, 2024, common shares outstanding: 5,997,246 (Jan 8, 2025: 5,977,246).","QUELIMMUNE (SCD-PED) FDA-approved Feb 2024; first commercial shipment July 2024; 4 hospital customers as of Q1 2025.","NEUTRALIZE-AKI adult pivotal trial 37% enrolled (74 of 200 subjects); 14 of 30 sites activated; CMS covers trial costs.","Four FDA Breakthrough Device Designations: adult AKI, cardiorenal syndrome w/ LVAD, hepatorenal syndrome, chronic dialysis.","Zero interest-bearing debt; cash use $11.3M YTD through Q3 2024; raised ~$20M new equity through Q3 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-002847","json":"https://secwatch.observer/filing/0001213900-25-002847.json","markdown":"https://secwatch.observer/filing/0001213900-25-002847.md","text":"https://secwatch.observer/filing/0001213900-25-002847.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1831868/000121390025002847/0001213900-25-002847-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1831868/000121390025002847/ea0227427-8k_seastar.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T03:46:30.362323+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}